592 related articles for article (PubMed ID: 21092521)
1. [OATP 1B1 T521C/A388G is an important polymorphism gene related to neonatal hyperbilirubinemia].
Zhang HX; Zhao X; Yang Z; Peng CY; Long R; Li GN; Li J; He ZK
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):650-5. PubMed ID: 21092521
[TBL] [Abstract][Full Text] [Related]
2. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
Zhang W; He YJ; Gan Z; Fan L; Li Q; Wang A; Liu ZQ; Deng S; Huang YF; Xu LY; Zhou HH
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1240-4. PubMed ID: 17973861
[TBL] [Abstract][Full Text] [Related]
3. Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays.
Op den Buijsch RA; Wijnen PA; van Dieijen-Visser MP; de Vries JE; Bekers O
Pharmacogenomics; 2005 Jun; 6(4):393-7. PubMed ID: 16004557
[TBL] [Abstract][Full Text] [Related]
4. Neonatal hyperbilirubinemia and organic anion transporting polypeptide-2 gene mutations.
Büyükkale G; Turker G; Kasap M; Akpınar G; Arısoy E; Günlemez A; Gökalp A
Am J Perinatol; 2011 Sep; 28(8):619-26. PubMed ID: 21500146
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of the UGT1A1 and OATP2 gene polymorphisms as major risk factor for unconjugated hyperbilirubinemia in Indian neonates.
D'Silva S; Colah RB; Ghosh K; Mukherjee MB
Gene; 2014 Aug; 547(1):18-22. PubMed ID: 24865931
[TBL] [Abstract][Full Text] [Related]
6. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
[TBL] [Abstract][Full Text] [Related]
7. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?
Alencastro de Azevedo L; Reverbel da Silveira T; Carvalho CG; Martins de Castro S; Giugliani R; Matte U
Pediatr Res; 2012 Aug; 72(2):169-73. PubMed ID: 22580719
[TBL] [Abstract][Full Text] [Related]
8. Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms.
Sato H; Uchida T; Toyota K; Nakamura T; Tamiya G; Kanno M; Hashimoto T; Watanabe M; Aoki K; Hayasaka K
J Hum Genet; 2015 Jan; 60(1):35-40. PubMed ID: 25391605
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
Sun G; Wang YL; Liang JF; Du LZ
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
[TBL] [Abstract][Full Text] [Related]
10. Exploring the genetic architecture of neonatal hyperbilirubinemia.
Watchko JF; Lin Z
Semin Fetal Neonatal Med; 2010 Jun; 15(3):169-75. PubMed ID: 20022574
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in Thai neonates with hyperbilirubinemia.
Prachukthum S; Nunnarumit P; Pienvichit P; Chuansumrit A; Songdej D; Kajanachumpol S; Pakakasama S; Hongeng S
Acta Paediatr; 2009 Jul; 98(7):1106-10. PubMed ID: 19397531
[TBL] [Abstract][Full Text] [Related]
12. Complex multifactorial nature of significant hyperbilirubinemia in neonates.
Watchko JF; Lin Z; Clark RH; Kelleher AS; Walker MW; Spitzer AR;
Pediatrics; 2009 Nov; 124(5):e868-77. PubMed ID: 19858149
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China.
Liu J; Long J; Zhang S; Fang X; Luo Y
Ital J Pediatr; 2013 Aug; 39():49. PubMed ID: 24090270
[TBL] [Abstract][Full Text] [Related]
14. Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
Boo NY; Sin S; Chee SC; Mohamed M; Ahluwalia AK; Ling MM; Ong HK
J Trop Pediatr; 2020 Dec; 66(6):569-582. PubMed ID: 32577754
[TBL] [Abstract][Full Text] [Related]
15. Variants of organic anion transporter polypeptide 2 gene are not risk factors associated with severe neonatal hyperbilirubinemia.
Wong FL; Boo NY; Ainoon O; Wang MK
Malays J Pathol; 2009 Dec; 31(2):99-104. PubMed ID: 20514852
[TBL] [Abstract][Full Text] [Related]
16. [Roles of UGT 1A1 gene mutation in the development of neonatal hyperbilirubinemia in Guangxi].
Gao ZY; Zhong DN; Liu Y; Liu YN; Wei LM
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):646-9. PubMed ID: 21092520
[TBL] [Abstract][Full Text] [Related]
17. Association between UGT 1A1 Gly71Arg (G71R) polymorphism and neonatal hyperbilirubinemia.
Prachukthum S; Gamnarai P; Kangsadalampai S
J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S13-7. PubMed ID: 23964438
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C polymorphisms and overall survival of breast cancer patients after tamoxifen therapy.
Zhang X; Pu Z; Ge J; Shen J; Yuan X; Xie H
Med Sci Monit; 2015 Feb; 21():563-9. PubMed ID: 25701109
[TBL] [Abstract][Full Text] [Related]
19. SLCO1B1 c.388A > G variant incidence and the severity of hyperbilirubinemia in Indonesian neonates.
Amandito R; Rohsiswatmo R; Halim M; Tirtatjahja V; Malik A
BMC Pediatr; 2019 Jun; 19(1):212. PubMed ID: 31253110
[TBL] [Abstract][Full Text] [Related]
20. [Changes of globus pallidus in the newborn infants with severe hyperbilirubinemia].
Mao J; Fu JH; Chen LY; Wang XM; Xue XD
Zhonghua Er Ke Za Zhi; 2007 Jan; 45(1):24-9. PubMed ID: 17349144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
